No abstract available.
Coronary Restenosis*

The efficacy of beta and gamma emitters in reducing clinical and angiographic restenosis in patients with in-stent restenosis has been confirmed by a number of studies. This review is intended to give an overview of the individual trials, summarize pertinent lessons that have been learned and give insight into the future of intracoronary radiation. The encouraging results from the clinical trials have established vascular brachytherapy as a standard of care for patients with in-stent restenosis.
Brachytherapy ; Coronary Restenosis ; Humans ; Standard of Care ; Stents

We report a case of in-stent restenosis due to the fracture of a sirolimus-eluting stent, which was confirmed by intravascular ultrasound. It can be suggested that a stent fracture is an important cause of restenosis in this era of drug-eluting stents.
Coronary Restenosis ; Drug-Eluting Stents* ; Stents ; Ultrasonography

Coronary Restenosis ; pathology ; Fibroblasts ; metabolism ; pathology ; Fibrosis

Constriction, Pathologic ; Coronary Restenosis ; Humans ; Inflammation ; Stents

Coronary Restenosis ; Drug-Eluting Stents ; Humans

Angioplasty, Balloon, Coronary ; Coronary Restenosis ; therapy ; Drug-Eluting Stents ; Humans

Angioplasty, Balloon, Coronary ; Coronary Restenosis ; Humans ; Practice Guidelines as Topic

Angioplasty, Balloon, Coronary ; Coronary Restenosis ; therapy ; Humans ; Stents

Coronary restenosis is still regarded as Achilles' Hill of interventional cardiology despite relentless efforts of many investigators. Recent experimental and clinical studies have suggested that both gamma and beta radiation can be reduce restenosis after angioplasty. Currently, intracoronary brachytherapy for the prevention of restenosis has become a new evolving treatment modality in interventional cardiology. This report discusses a physical aspect of gamma and beta radiation, initial clinical results and delivery systems used in intracoronary brachytherapy. We shall take a brief overview of methods and their advantages in intracoronary brachytherapy. Future work should provide further insight for the best way of treating restenosis.
Angioplasty ; Beta Particles ; Brachytherapy ; Cardiology ; Coronary Restenosis ; Humans ; Research Personnel